Integrated DNA Technologies (IDT) introduces its rhAmpSeq targeted sequencing system, providing researchers with easy-to-use amplicon sequencing on Illumina next-generation sequencing (NGS) platforms.
Researchers have developed a sensitive new biosensor that could someday be used to detect foetal Down syndrome DNA in pregnant women's blood.
PerkinElmer has more than 150 tested automated methods available for the most frequently used NGS library prep kit.
Nanotechnology researchers have reported a low-cost way of detecting cancer in early stages using a new class of magnetic nanomaterials.
The Harry Perkins Institute of Medical Research (HPIMR) has installed an Illumina NovaSeq 6000 DNA sequencer.
In a study conducted by GE Healthcare, researchers examined the yield and quality of DNA from blood samples applied to Whatman FTA cards, using five common methods of DNA extraction.
New research from Emory University shows that the human RNA molecule called nc886 may be a key player in human cells' frontline defences against viruses.
SA Water scientists are using DNA to search for shy platypus, and the presumed-extinct thylacine.
Bio-Rad Laboratories has announced the IncRNA Workflow, a RT-qPCR workflow that is optimised for highly sensitive and specific quantification of long noncoding RNAs (lncRNAs) for gene expression analysis. The workflow provides a streamlined alternative to RNA-Seq for lncRNA discovery and validation.
The osteomiR microRNA signature is intended to assess the risk of a first fracture in female patients of postmenopausal osteoporosis and type 2 diabetes. This information enables timely interventions and can help to avoid fractures.
The iSeq 100 Sequencing System is a small and accessible sequencer from Illumina. Designed for simplicity, it allows labs of all sizes to sequence DNA and RNA at the push of a button.
Scientists have developed a new system to identify and characterise the molecular components that control the activities of regulatory DNA sequences in the human genome.
US scientists have used CRISPR to edit human embryos, removing a mutation linked to a heritable heart condition.
Scientists have identified important processes that create cancer-causing mutations by studying the genomes of more than 1000 tumours.
Scientists in the US have reportedly modified the genes of human embryos using CRISPR.